Eosinophilic Duodenitis (EoD) clinical trials at UCSF
1 research study open to eligible people
Eosinophilic duodenitis (EoD) is a condition where certain white blood cells cause inflammation in the intestines. UCSF is researching how Dupilumab helps adults and teens with eosinophilic gastritis and duodenitis. The study also checks for any side effects.
Showing trials for
Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
open to eligible people ages 12 years and up
This study is researching an experimental drug called dupilumab. The study is focused on participants with active eosinophilic gastritis (EoG) with or without eosinophilic duodenitis (EoD). Participants with EoD only are not eligible for enrollment. …
San Francisco, California and other locations
Last updated: